companydata.dkcompanydata.dk

PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2019

CVR: 32478697

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 455,385 and a net result of DKK 433,812 compared with DKK 211,199 the year before. That is an increase of 115.5% compared with the year before. Equity in the 2019 report amounted to DKK 567,034. The solvency ratio was 73.2%.

Gross Profit
DKK 455,385
Profit/Loss
DKK 433,812
Equity
DKK 567,034
Total Assets
DKK 774,469

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-455 t.434 t.567 t.-
2018-211 t.211 t.133 t.-
2017-494 t.494 t.-78 t.-
2016-355 t.355 t.-572 t.-
2015-96 t.92 t.-927 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

PHARMAZAN PHARMACEUTICALS ApS: The 2018 annual report is outMay 31, 2019

PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK 211,341, and the net result was DKK 211,199.

About PHARMAZAN PHARMACEUTICALS ApS

PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.

Source: annual report 2025, Danish Business Authority